Bayasgalan Tumenbayar

FULL NAME Bayasgalan Tumenbayar
ACADEMIC DEGREE MD., Ph.D.
AFFILIATION Department of Internal Medicine, School of Medicine, Mongolian National University of Medical Sciences
EDUCATION Jichi University, Japan
FIELD OF SPECIALIZATION  Medicine, Endocrinology, Neuroscience
RESEARCH INTERESTS
PUBLICATIONS
  1. Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and death. Nagashima S, Yagyu H, Ohashi K, Tazoe F, Takahashi M, Ohshiro T, Bayasgalan T, Okada K, Sekiya M, Osuga J, Ishibashi S. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1824-31. doi: 10.1161/ATVBAHA.111.240754. Epub 2012 Jun 14. PMID: 22701022
  2. Molecular analysis of a novel LCAT mutation (Gly179 → Arg) found in a patient with complete LCAT deficiency. Wang XL, Osuga J, Tazoe F, Okada K, Nagashima S, Takahashi M, Ohshiro T, Bayasgalan T, Yagyu H, Okada K, Ishibashi S. J Atheroscler Thromb. 2011;18(8):713-9. Epub 2011 May 20. PMID: 21597230
  3. Depot-specific expression of lipolytic genes in human adipose tissues–association among CES1 expression, triglyceride lipase activity and adiposity. Nagashima S, Yagyu H, Takahashi N, Kurashina T, Takahashi M, Tsuchita T, Tazoe F, Wang XL, Bayasgalan T, Sato N, Okada K, Nagasaka S, Gotoh T, Kojima M, Hyodo M, Horie H, Hosoya Y, Okada M, Yasuda Y, Fujiwara H, Ohwada M, Iwamoto S, Suzuki M, Nagai H, Ishibashi S. J Atheroscler Thromb. 2011;18(3):190-9. Epub 2010 Nov 11. PMID: 21081832
  4. Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes. Eto K, Tumenbayar B, Nagashima S, Tazoe F, Miyamoto M, Takahashi M, Ando A, Okada K, Yagyu H, Ishibashi S. Diabetes Res Clin Pract. 2010 Jul;89(1):52-7. doi: 10.1016/j.diabres.2010.03.019. Epub 2010 May 7. PMID: 20452080
MEMBERSHIP Mongolian Neuroscience Society
AWARDS
CONTACT

Comments are closed